Charlie Kemp, associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory, has been selected to receive the 2017 Class of 1940 Course Survey Teaching Effectiveness Award.
This award recognizes no more than 40 Georgia Tech faculty members who excel in the eyes of their students measured by their scores on end-of-course instructor evaluations. Only faculty members with a high response rate and a near-perfect evaluation score on the Course-Instructor Opinion Survey (CIOS) are considered and nominations are not allowed.
Kemp’s research focuses on robotics with an emphasis on mobile manipulation and human-robot interaction in the context of healthcare. He has adjunct appointments in the School of Interactive Computing and the School of Electrical and Computer Engineering. He is the director of the healthcare robotics lab and is training the next generation of engineering students in healthcare robotics technologies, so they can better understand the changing needs of patients, their caregivers and healthcare providers.
The award is given by Georgia Tech’s Center for the Enhancement of Teaching and Learning (CETL). Award recipients will be recognized at the Center’s Celebrating Teaching Day on March 8, 2018.
Media Contact
Walter Rich
Keywords
Latest BME News
Researchers demonstrate stem cell treatment without chemotherapy and painful bone marrow procedure
BME researchers explore the critical role of mechanical force in rare genetic disorder
Researchers develop spatial transcriptomics toolkit that provides new insights into the molecular processes of life
Air Detectives take top prize to give department three straight victories in Expo competition
Coulter BME community gathers at the Fabulous Fox to celebrate anniversary of unique public-private partnership
Coskun pioneering new research area and building a company around iseqPLA technology
BME undergraduate student and competitive skater Sierra Venetta has found success on and off the ice
BME researcher Ankur Singh using new technology to uncover weakened response in cancer patients